Healthcare institutions and laboratories are encouraged to exercise and continue to practice appropriate clinical precautions when handling breath samples from patients. These groups should refer to their own policies on how to handle its COVID-19 response and should respond appropriately as the COVID-19 situation applies to and impacts its breath testing in its facilities.

Judgement on whether or not to test a patient using the BreathTek® UBT for H. pylori Kit should continue to be made by the patient’s prescribing physician and in collaboration with local testing laboratories on an individual patient basis.

While the COVID-19 situation continues to be dynamic, Otsuka sources the components of the BreathTek® UBT in the United States and currently does not foresee disruptions to its supply.

April 202005US20EBP0007

Healthcare institutions and laboratories are encouraged to exercise and continue to practice appropriate clinical precautions when handling breath samples from patients. These groups should refer to their own policies on how to handle its COVID-19 response and should respond appropriately as the COVID-19 situation applies to and impacts its breath testing in its facilities.

Judgement on whether or not to test a patient using the BreathTek® UBT for H. pylori Kit should continue to be made by the patient’s prescribing physician and in collaboration with local testing laboratories on an individual patient basis.

While the COVID-19 situation continues to be dynamic, Otsuka sources the components of the BreathTek® UBT in the United States and currently does not foresee disruptions to its supply.

April 202005US20EBP0007

Comparing Diagnostic Methods

ACG guidelines recommend urea breath test (UBT), fecal antigen test (FAT), and endoscopy for eradication testing.1

ACG guidelines no longer include serology in H. pylori testing recommendations since it is not a test for active infection2

Some diagnostic labs have discontinued offering serologic testing for H. pylori3,4

Stool testing is associated with relatively low patient adherence5,6

In one study, more patients returned for a post-treatment UBT vs FAT (N=29)6

Stool Testing Post Treatment

vs

Fecal occult blood

BreathTek® UBT for H. pylori aligns with guideline recommendations to test, treat, and confirm eradication of H. pylori infection.

Abbreviation: ACG, American College of Gastroenterology.

References
  • Chey WD, Leontiadis GI, Howden CW, Moss SF. ACG clinical guideline: treatment of helicobacter pylori infection. Am J Gastroenterol. 2017;112(2):212-238. https://acgcdn.gi.org/wp-content/uploads/2018/04/ACG-H.-pylori-Guideline-Summary.pdf. Accessed October 1, 2019.
  • Chey WD, Wong BCY; Practice Parameters Committee of the American College of Gastroenterology. American College of Gastroenterology guideline on the management of Helicobacter pylori infection. Am J Gastroenterol. 2007;102(8):1808-1825.
  • Mayo Clinic. Mayo Laboratories. Hot topic. Helicobacter pylori -- an update on diagnostic testing. Published February 1, 2016. https://news.mayomedicallaboratories.com/2016/02/01/helicobacter-pylori-an-update-on-diagnostic-testing-hot-topic/. Accessed March 12, 2019.
  • Quest Diagnostics. Helicobacter pylori Infection: Laboratory Support of Diagnosis and Management. http://www.questdiagnostics.com/testcenter/testguide.action?dc=CF_Hpylori. Accessed March 12, 2019.
  • Ore L, Hagoel L, Lavi I, Rennert G. Screening with faecal occult blood test (FOBT) for colorectal cancer: assessment of two methods that attempt to improve compliance. Eur J Cancer Prev. 2001;10(3):251-256.
  • Cullen KP, Broderick BM, Jayaram J, Flynn B, O'Connor HJ. Evaluation of the Helicobacter pylori stool antigen (HpSA) test in routine clinical practice—is it patient-friendly? Ir Med J. 2002;95(10):305-306.